Welcome to the Global ETF Awards Speakers 13th Annual ETF Global Awards Click here to view image
Rory Riggs
CEO, Founder SYNTAX

Rory Riggs is the CEO and Founder of Syntax Indices in 2008. Prior to founding Syntax and its parent, Locus Analytics, Rory has been involved in the creation and development of many successful companies in healthcare and bio-technology including. He is currently the chairman and co-founder of Royalty Pharma, the largest investor in revenue-producing intellectual property, principally royalty interests in marketed and late-stage development biopharmaceutical products. In addition, Rory is Chairman and co-founder of Cibus, the leader in non-transgenic (non-GMO) gene editing in agriculture. He also served as the president and director of Biomatrix Corporation (NYSE: BXM). Rory received a BA from Middlebury College and an MBA from Columbia University.